posted
Advanced Plant Pharmaceuticals Rated 'Speculative Buy,' Target Price $0.06 by Beacon Equity Research
Friday , February 02, 2007 16:05ET
DALLAS, Feb 02, 2007 (BUSINESS WIRE) -- Advanced Plant Pharmaceuticals (OTCBB:APPI) has been rated "Speculative Buy" with a target price of $0.06 by Beacon Equity Research Analyst Dr. Victor Sula.
Anyone interested in receiving alerts regarding Advanced Plant Pharmaceuticals research should email members*beaconequityresearch.com with "APPI" in the subject line.
In the report, Dr. Sula writes, "Advanced Plant Pharmaceuticals, Inc. is shifting its business plan to focus on biofuels and renewable energy production and distribution. In Q4FY06, APPI announced an agreement to acquire World Health Energy (WHE), a renewable energy company focused on the development and production of alternative fuels. WHE plans to use cost-effective agricultural products both locally and from around the world to develop natural alternative fuels. The Company plans to build two biodiesel plants in the US and is in the process of securing financing for their construction."
"According to Clean Edge research, the global biofuels market will grow from $15.7 billion in 2005 to $52.5 billion by 2015. Meanwhile, Emerging Markets Online forecasts US biodiesel consumption will grow to 750 million gallons by the end of 2007. Moreover, the US biodiesel market should grow significantly to match the consumption levels of European counterparts. Total biodiesel sales in the US amounted to less than 0.5% of all petro-diesel on-road consumption in 2005."
"We believe the Company's market capitalization and valuation will gravitate towards its bio-fuel peers. Many early-stage bio-fuel companies are trading at huge premiums to other industry medians. Competitors such as Earth Biofuels (OTCBB:EBOF), Pacific Ethanol (Nasdaq:PEIX), Verasun Energy (NYSE:VSE) and Southridge Ethanol (OTCBB:SORD) trade at a P/S multiple of roughly 10 or less."
Beacon Equity Research Disclosure
The analysts contributing to this report do not hold any shares of Advanced Plant Pharmaceuticals (APPI). Additionally, the analysts contributing to this report certify that the views expressed herein accurately reflect the analysts' personal views as to the subject securities and issuers. The analyst(s) writing this report recognize and aspire to all of the CFA Institute Guidelines for Independent Research. Beacon Equity Research ("Beacon") certifies that no part of the analysts' compensation was, is, or will be, directly or indirectly, related to the specific recommendation or views expressed by the analysts in the report. Beacon has directly been compensated seven thousand five hundred dollars by Oceanic Consulting for enrollment in its research program. This report is based on data obtained from sources we believe to be reliable, but is not guaranteed as to accuracy and does not purport to be complete. As such, the report should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed herein are subject to change.
SOURCE: Advanced Plant Pharmaceuticals
Beacon Equity Research Jeff Bishop, 469-252-3035 editor*beaconequityresearch.com www.BeaconEquityResearch.com or Advanced Plant Pharmaceuticals Rick Lutz, 404-261-1196 ir*advancedplantpharm.com
Copyright Business Wire 2007
-------------------- " Cash is King " Posts: 1102 | From: NJ | Registered: Mar 2006
| IP: Logged |
posted
This has already been posted on other thread, no new news!!!
Posts: 782 | From: Warm Southern end of Maine, YA RIGHT!! | Registered: Oct 2006
| IP: Logged |
posted
Advanced Plant Pharmaceuticals, Inc. Announces Completion of Acquisition of Biodiesel Producer World Health Energy, Inc. Company to Be Renamed World Health Energy, Inc. to Reflect New Business Plan Focused on Rapidly Growing Renewable Energy Market Feb 9, 2007 4:20:00 PM NEW YORK, NY -- (MARKET WIRE) -- 02/09/07 -- Advanced Plant Pharmaceuticals, Inc. (OTCBB: APPI) today announced the closing of its acquisition of World Health Energy, Inc., an emerging energy company focused on biofuels and renewable energy production and distribution. A Current Report on Form 8-K containing details of this transaction will be filed with the Securities and Exchange Commission on or before February 13, 2007.
APPI's board of directors has adopted a resolution to change its corporate name to World Health Energy, Inc., to reflect the acquisition of World Health Energy, Inc. and the new business plan to focus on biofuels and renewable energy production and distribution. APPI anticipates the name change will be completed within thirty days. A new ticker symbol to reflect the corporate name of World Health Energy, Inc. will be issued after the name change has been effected.
World Health Energy, Inc. plans to use renewable, cost-effective agricultural products domestically and around the world to develop natural alternative fuels. World Health Energy's proposed biodiesel production plants are expected to be designed to produce biodiesel that complies to or exceeds international biodiesel production requirements and standards, including the European standard for Biodiesel EN 14214 as well as ASTM D6751 specifications.
The company plans on utilizing ultrasonic processing to produce its biodiesel, which the company's management believes is more effective (than the conventional batch reactor process). This ultrasonic process can produce biodiesel (with yield in excess of 99%) in under 5 minutes as compared to the conventional batch reactor process which can require an hour or more. The company believes that the higher yielding process should provide the company with production cost advantages.
To be added to Advanced Plant Pharmaceutical's corporate e-mail list for shareholders and interested investors, please send an e-mail to ir*advancedplantpharm.com.
About World Health Energy, Inc. (http://www.worldhealthenergy.com)
World Health Energy, Inc. is a renewable energy company focused on developing and producing alternative fuels. WHE's proposed biodiesel production plants are designed to produce biodiesel that complies to or exceeds international biodiesel production requirements and standards, including the European standard for Biodiesel EN 14214, as well as ASTM D6751 specifications.
About Advanced Plant Pharmaceuticals, Inc. (http://www.advancedplantpharm.com)
Advanced Plant Pharmaceuticals, Inc. (OTCBB: APPI) has focused on the research and development of whole plant-based nutritionals. The company has a composition-oriented patent for a proprietary process of utilizing whole plants to safely manufacture all-natural nutritional supplements. APPI markets and distributes its line of products including Lo-Chol(TM) worldwide through various sales distribution channels. The company is currently in the initial stages of shifting its business plan to enter the rapidly growing renewable energy market.
"Safe Harbor Statement" Under The Private Securities Litigation Reform Act Of 1995
This press release contains forward-looking statements that involve risks and uncertainties. The statements in this release are forward-looking statements that are made pursuant to safe harbor provision of the Private Securities Litigation Reform Act of 1995. Actual results, events and performance could vary materially from those contemplated by these forward-looking statements. These statements involve known and unknown risks and uncertainties, which may cause Advanced Plant Pharmaceuticals, Inc.'s actual results in future periods to differ materially from results expressed or implied by forward-looking statements. These risks and uncertainties include, among other things, product demand and market competition. You should independently investigate and fully understand all risks before making investment decisions.
Contact: Advanced Plant Pharmaceuticals, Inc. Investor Relations LC Group Rick Lutz (404) 261-1196 ir*advancedplantpharm.com
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
Completion of Acquisition or Disposition of Assets, Financial
Item 2.01 Completion of Acquisition or Disposition of Assets. On February 7, 2007, Advanced Plant Pharmaceuticals, Inc., a Delaware corporation, consummated its acquisition of all of the outstanding equity of World Health Energy, Inc., a Delaware corporation pursuant to the terms and conditions of that certain Securities Purchase Agreement and Plan of Reorganization (the "Agreement") dated as of January 9, 2007 by and among APPI, WHE and the stockholders of WHE. Pursuant to the Agreement, APPI agreed to issue 55,000,000 shares of its common stock, par value $0.0007 per share (the "Shares") to Edwin Zhao and David Miedzygorski, the sole stockholders of WHE as follows: (i) 5,000,000 Shares at Closing and (ii) 50,000,000 Shares within 3 days of the filing of an amendment to APPI's Articles of Incorporation with the Delaware Secretary of State to either (A) increase the Company's authorized Common Stock to at least 930,000,000 (a "Capitalization Increase") or (B) to effectuate a reverse split of the Company's Common Stock (the "Reverse Split"). If the Company effects a Reverse Split prior to any Capitalization Increase, the Remaining Shares due Selling Stockholders shall be proportionately reduced to give effect to the Reverse Split. For example, if the Company effects a 1-for-10 Reverse Split, only 5,000,000 Shares would be issued. The Company is under no obligation to take any action to effect either a Capitalization Increase or a Reverse Split.
These issuances were exempt under Section 4(2) of the Securities Act of 1933, as amended.
This description of the Agreement does not purport to be complete and is qualified in its entirety by reference to the Agreement, which is incorporated herein by reference.
The way I read it is they will either do a reverse split, increase the AS or do nothing. LOL. It aint nothing like being a little wishy washy. TMAN...
-------------------- In the end, trust only yourself when trading stocks. Posts: 2048 | From: Texas | Registered: Feb 2006
| IP: Logged |
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Smile]](smile.gif)
![[Wink]](wink.gif)
![[Eek!]](eek.gif)
